1Ghirlanda G,Oradei A,Manto A,et al.Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors:a double-blind,placebo-controlled study[J].J Clin Pharmacol,1993,33(3):226.
2Watts GF,Castelluccio C,Rice-Evans C,et al.Plasma coenzyme Q(ubiquinone)concentrations in patients treated with simvastatin[J].J Clin Pathol,1993,46(11):1 055.
3De Pinieux G,Chariot P,Ammi-Said M,et al.Lipidlowering drugs and mitochondrial function:effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio[J].Br J Clin Pharmacol,1996,42(3):333.
4Lorgeril M,Salen P,Bontemps L,et al.Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients[J].J Cardiovasc Pharmacol,1999,33(3):473.
5Mortensen SA,Leth A,Agner E,et al.Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors[J].Molecular Aspects of Medicine,1997,18(Suppl 1):s137.
6Passi S,Stancato A,Aleo E,et al.Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA[J].Biofactors,2003,18(1～ 4):113.
7Rundek T,Naini A,Sacco R,et al.Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke[J].Arch Neurol,2004,61(6):889.
